Publication:
Pooled sequencing and rare variant association tests for identifying the determinants of emerging drug resistance in malaria parasites

dc.contributor.authorIan H. Cheesemanen_US
dc.contributor.authorMarina McDew-Whiteen_US
dc.contributor.authorAung Pyae Phyoen_US
dc.contributor.authorKanlaya Sriprawaten_US
dc.contributor.authorFrancois Nostenen_US
dc.contributor.authorTimothy J.C. Andersonen_US
dc.contributor.otherTexas Biomedical Research Instituteen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherNuffield Department of Clinical Medicineen_US
dc.date.accessioned2018-11-23T09:31:30Z
dc.date.available2018-11-23T09:31:30Z
dc.date.issued2015-04-01en_US
dc.description.abstract© The Author 2014. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution. We explored the potential of pooled sequencing to swiftly and economically identify selective sweeps due to emerging artemisinin (ART) resistance in a South-East Asian malaria parasite population. ART resistance is defined by slow parasite clearance from the blood of ART-treated patients and mutations in the kelch gene (chr. 13) have been strongly implicated to play a role. We constructed triplicate pools of 70 slow-clearing (resistant) and 70 fast-clearing (sensitive) infections collected from the Thai-Myanmar border and sequenced these to high (∼150-fold) read depth. Allele frequency estimates from pools showed almost perfect correlation (Lin's concordance = 0.98) with allele frequencies at 93 single nucleotide polymorphisms measured directly from individual infections, giving us confidence in the accuracy of this approach. By mapping genome-wide divergence (FST) between pools of drug-resistant and drug-sensitive parasites, we identified two large (>150 kb) regions (on chrs. 13 and 14) and 17 smaller candidate genome regions. To identify individual genes within these genome regions, we resequenced an additional 38 parasite genomes (16 slow and 22 fast-clearing) and performed rare variant association tests. These confirmed kelch as a major molecular marker for ART resistance (P = 6.03 × 10-6). This two-tier approach is powerful because pooled sequencing rapidly narrows down genome regions of interest, while targeted rare variant association testing within these regions can pinpoint the genetic basis of resistance. We show that our approach is robust to recurrent mutation and the generation of soft selective sweeps, which are predicted to be common in pathogen populations with large effective population sizes, and may confound more traditional gene mapping approaches.en_US
dc.identifier.citationMolecular Biology and Evolution. Vol.32, No.4 (2015), 1080-1090en_US
dc.identifier.doi10.1093/molbev/msu397en_US
dc.identifier.issn15371719en_US
dc.identifier.issn07374038en_US
dc.identifier.other2-s2.0-84988299737en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/35179
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84988299737&origin=inwarden_US
dc.subjectAgricultural and Biological Sciencesen_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.titlePooled sequencing and rare variant association tests for identifying the determinants of emerging drug resistance in malaria parasitesen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84988299737&origin=inwarden_US

Files

Collections